Page last updated: 2024-08-22

buthionine sulfoximine and Armstrong Syndrome

buthionine sulfoximine has been researched along with Armstrong Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brenner, D; Grusdat, M; Harris, IS; Häussinger, D; Hengartner, H; Honke, N; Lang, E; Lang, KS; Lang, PA; Mak, TW; Maney, SK; McIlwain, DR; Odermatt, B; Ohashi, PS; Pandyra, AA; Pozdeev, VI; Recher, M; Shaabani, N; Xu, HC; Zinkernagel, RM	1

Other Studies

1 other study(ies) available for buthionine sulfoximine and Armstrong Syndrome

Article	Year
Reactive oxygen species delay control of lymphocytic choriomeningitis virus. Cell death and differentiation, 2013, Volume: 20, Issue:4 Topics: Animals; Buthionine Sulfoximine; CD8-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; Disease Models, Animal; Glutathione; Liver; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Reactive Oxygen Species; Spleen	2013

Article

Year

Reactive oxygen species delay control of lymphocytic choriomeningitis virus.

Cell death and differentiation, 2013, Volume: 20, Issue:4

Topics: Animals; Buthionine Sulfoximine; CD8-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; Disease Models, Animal; Glutathione; Liver; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Reactive Oxygen Species; Spleen

2013